As a global biopharmaceutical company, our responsibility to society starts with making quality, trusted medicines that make life better for people around the world. This is the core of what we do. And by doing this well, it allows us to extend our reach and deepen the impact of our corporate responsibility efforts.
Beyond the medicines we make, we leverage our research and development (R&D) capabilities, expertise, assets and the passion of our scientists to advance research and scientific discovery.
Our primary philanthropic R&D focus over the past decade has been around tuberculosis, a disease for which new, safer, faster-acting medicines are desperately needed. Through the Lilly MDR-TB Partnership, we support TB discovery efforts in partnership with leading R&D organizations, non-profits, academic institutions and governments.
"Research is the heart of the business, the soul of the enterprise."- Mr. Eli Lilly (Grandson of the Company Founder, Colonel Eli Lilly)